BR112013019251A2 - processo para a preparação de um extrato de ervas - Google Patents

processo para a preparação de um extrato de ervas

Info

Publication number
BR112013019251A2
BR112013019251A2 BR112013019251A BR112013019251A BR112013019251A2 BR 112013019251 A2 BR112013019251 A2 BR 112013019251A2 BR 112013019251 A BR112013019251 A BR 112013019251A BR 112013019251 A BR112013019251 A BR 112013019251A BR 112013019251 A2 BR112013019251 A2 BR 112013019251A2
Authority
BR
Brazil
Prior art keywords
preparing
herbal extract
provides
present
momordica charantia
Prior art date
Application number
BR112013019251A
Other languages
English (en)
Inventor
Ashish Suthar
Somesh Sharma
Vijay Singh Chauhan
Original Assignee
Piramal Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46580277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013019251(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Piramal Entpr Ltd filed Critical Piramal Entpr Ltd
Publication of BR112013019251A2 publication Critical patent/BR112013019251A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/31Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)

Abstract

processo para a preparação de um extrato de ervas a presente invenção proporciona um processo para a extração dos componentes ativos de momordica charantia, que é simples, de baixo custo, não utiliza qualquer solventes orgânicos prejudiciais de que aumenta a potência dos componentes. a presente invenção também pfroporciona uma formulação simples e potente, exibindo atividade anti-diabética, compreendendo constituintes ativos de momordica charantia.
BR112013019251A 2011-01-28 2012-01-27 processo para a preparação de um extrato de ervas BR112013019251A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN246MU2011 2011-01-28
PCT/IN2012/000059 WO2012101657A1 (en) 2011-01-28 2012-01-27 Process for preparation of a herbal extract

Publications (1)

Publication Number Publication Date
BR112013019251A2 true BR112013019251A2 (pt) 2016-10-11

Family

ID=46580277

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013019251A BR112013019251A2 (pt) 2011-01-28 2012-01-27 processo para a preparação de um extrato de ervas

Country Status (19)

Country Link
US (1) US9034400B2 (pt)
EP (1) EP2667884B1 (pt)
JP (1) JP6018583B2 (pt)
KR (1) KR20140038372A (pt)
CN (1) CN103458906B (pt)
BR (1) BR112013019251A2 (pt)
CA (1) CA2825845C (pt)
CL (1) CL2013002172A1 (pt)
EC (1) ECSP13012854A (pt)
ES (1) ES2621355T3 (pt)
HU (1) HUE032416T2 (pt)
IL (1) IL227677A (pt)
MX (1) MX2013008754A (pt)
MY (1) MY162398A (pt)
PE (1) PE20140728A1 (pt)
RU (1) RU2586770C2 (pt)
UA (1) UA112174C2 (pt)
WO (1) WO2012101657A1 (pt)
ZA (1) ZA201305700B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016005576A (es) * 2013-10-28 2016-12-09 Piramal Entpr Ltd Composicion herbaria, procedimiento para su preparacion y uso de la misma.
US10675319B2 (en) 2016-06-21 2020-06-09 Tci Co., Ltd. Method for regulating circadian clock, regulating diurnal preference, adjusting a biological clock, improving sleep quality and/or facilitating sleep by using momordica charantia extract
CN107468729A (zh) * 2017-08-17 2017-12-15 广西壮族自治区农业科学院农产品加工研究所 一种明日叶提取物的提取方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN81887B (pt) 1962-04-23 1975-08-16 M Rao
GB1435664A (en) 1974-07-08 1976-05-12 Khanna P Nag T N Jain S C Process for isolation if insulin
US5098710A (en) 1987-06-18 1992-03-24 Yaguang Liu Production of kuguasu
CN1180545A (zh) 1996-10-24 1998-05-06 谢春生 一种复方苦瓜制剂
KR100509438B1 (ko) 1997-04-01 2005-08-23 테라코스, 인코포레이티드 경구적으로 활성인 여주의 분획, 이것의 활성 펩티드 및 당뇨병 치료에 있어서 이들의 사용
CA2369908C (en) 1999-04-13 2013-03-12 Pushpa Khanna Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof
CN1098858C (zh) * 1999-07-30 2003-01-15 王力 苦瓜素的提取工艺
CN1303698A (zh) 1999-12-02 2001-07-18 潘君琦 一种苦瓜降糖胶囊及其制备工艺
CN1290575A (zh) * 1999-12-28 2001-04-11 孙进元 一种选矿用浮选剂
IN188858B (pt) * 2000-08-11 2002-11-16 Ajanta Pharma Ltd
CN102670453A (zh) * 2001-10-09 2012-09-19 株式会社芳凯尔 一种组合物a在制备美白用组合物中的应用
CN1418890A (zh) 2002-09-23 2003-05-21 北海海玉农业开发有限责任公司 一种苦瓜降糖多肽的制备方法
JP2005126370A (ja) 2003-10-23 2005-05-19 Media Price Co Ltd 苦瓜を原料とするモモルデシンの回収方法
CN1290575C (zh) 2004-03-22 2006-12-20 武汉大学 含活性蛋白质的苦瓜降糖原药的制备方法
CN1858223A (zh) 2005-04-30 2006-11-08 邹远东 苦瓜多肽的制备方法和用途
JP2006314273A (ja) 2005-05-13 2006-11-24 Media Price Co Ltd 苦瓜を原料とするモモルデシンの回収方法
CN1302003C (zh) 2005-06-30 2007-02-28 天津农学院 苦瓜皂甙和苦瓜多糖的综合提取方法
CN100506238C (zh) 2006-04-21 2009-07-01 江苏大学 一种苦瓜多糖降血糖组合物及其制备方法
JP2008120701A (ja) 2006-11-09 2008-05-29 Kuniaki Nejime 血糖値低下剤
CN101223967A (zh) * 2008-02-01 2008-07-23 广州蓝韵医药研究有限公司 苦瓜系列食品的制备方法
CN101366806B (zh) 2008-07-24 2011-06-08 吴茂玉 一种苦瓜冻干粉的制造方法
CN101461514B (zh) 2009-01-22 2011-11-30 韩金光 苦瓜提取物的制备方法
CN101485429B (zh) 2009-02-25 2013-03-27 武汉科技大学 一种可降糖的苦瓜冻干粉的制备方法
CN101637491B (zh) 2009-06-10 2011-03-30 北京一品堂医药科技有限公司 一种具有辅助降血糖、辅助降血脂功能的保健食品及其制备方法
CN101597389B (zh) 2009-07-03 2010-10-13 广东省农业科学院农业生物技术研究所 一种苦瓜皂甙和多糖混合物及其提取工艺与应用

Also Published As

Publication number Publication date
AU2012210142A8 (en) 2013-09-12
RU2013139644A (ru) 2015-03-10
US20140087012A1 (en) 2014-03-27
US9034400B2 (en) 2015-05-19
RU2586770C2 (ru) 2016-06-10
PE20140728A1 (es) 2014-07-05
AU2012210142A1 (en) 2013-08-15
JP6018583B2 (ja) 2016-11-02
MY162398A (en) 2017-06-15
HUE032416T2 (en) 2017-09-28
IL227677A0 (en) 2013-09-30
JP2014505071A (ja) 2014-02-27
IL227677A (en) 2016-11-30
CA2825845A1 (en) 2012-08-02
ECSP13012854A (es) 2013-11-29
CN103458906A (zh) 2013-12-18
UA112174C2 (uk) 2016-08-10
WO2012101657A1 (en) 2012-08-02
CL2013002172A1 (es) 2014-10-17
EP2667884A1 (en) 2013-12-04
KR20140038372A (ko) 2014-03-28
EP2667884B1 (en) 2017-01-04
EP2667884A4 (en) 2014-10-22
ES2621355T3 (es) 2017-07-03
CN103458906B (zh) 2016-05-25
CA2825845C (en) 2019-08-27
ZA201305700B (en) 2014-07-30
MX2013008754A (es) 2015-10-29

Similar Documents

Publication Publication Date Title
DOP2019000005A (es) 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2
ECSP16062173A (es) Derivados de ácido heteroaril butanóico como inhibidores de lta4h
BR112018076169A2 (pt) derivados azabenzimidazol como inibidores de pi3k beta
BR112016029053A2 (pt) derivados de fulereno
BR112015022174A2 (pt) esteróides neuroativos e métodos de uso dos mesmos
CL2015002164A1 (es) Formulación combinada de dos compuesos antivirales.
BR112015022191A2 (pt) compostos heteroarila, seu uso e composição que os compreende
EA201690753A1 (ru) Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств
UY35455A (es) Inhibidores tripeptidicos de la epoxicetona proteasa
NI201600014A (es) Compuestos y composiciones como inhibidores de la mek.
BR112013031493A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto.
BR112014030655A8 (pt) Compostos inibidores de pirimidinil tirosina quinase, e composição farmacêutica que os compreende
CR20150390A (es) Inhibidores de la yodoproteina basada en 2,3-dihidroimidazol[1,2-c]pirimidin-5(1-h)-ona-asociada a la fosfolipasa a2 (lp-pla2)
BR112015029462A2 (pt) Inibidores de quinase
BR112016000565A2 (pt) polipeptídeo cíclico, derivado ou análogo do mesmo e seu uso modulador alostérico, composição farmacêutica, processo para produzir a mesma
BR112019021867A2 (pt) Compostos de fenil-2-hidroxi-acetilamino-2-metil-fenil
BR112016029842A2 (pt) conjugados de anticorpo anti-cd22-fármaco e métodos de uso dos mesmos
DOP2017000244A (es) Derivados de pirazol útiles como inhibidores de proteína activadora de 5-lipoxigenasa (flap)
BR112017002852A2 (pt) compostos de azetidiniloxifenilpirrolidina
CL2013003625A1 (es) Compuestos derivados de tetrahidroquinolinas condensadas con un cicloalquilo; formulacion farmaceutica que los comprende; y uso como moduladores de receptores de crth2 en el tratamiento del asma, rinitis alergica o epoc.
BR112018007068A2 (pt) derivados de quinoxalina e piridopirazina como inibidores de pi3kbeta
PL2964023T3 (pl) Zastosowanie n-(2-metoksybenzoilo)- 4-[(metyloaminokarbonylo)amino]benzenosulfonamidu w kombinacji ze środkiem owadobójczym lub fungicydem dla zwiększenia plonów roślin
BR112013019251A2 (pt) processo para a preparação de um extrato de ervas
BR112016013946A8 (pt) quinazolin-thf-aminas como inibidores de pde1, composição farmacêutica que os compreende, processo para preparação da referida composição farmacêutica, bem como uso dos composto e kit
BR112015006844A2 (pt) um elemento de contato com a pele que compreende ao menos uma substância sensibilizante termicamente resiliente

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2498 DE 21/11/2018.

B350 Update of information on the portal [chapter 15.35 patent gazette]